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Abstract
Reports of birth defects rates may focus on defects observed in the newborn period or include
defects diagnosed at older ages. However, little information is available on the rates of additional
anomalies detected after birth or on the ages at which such anomalies are diagnosed. The aims of
this work were to describe the initial diagnoses of oral clefts, isolated or associated with other
defects, in newborn infants ascertained in hospitals of the ECLAMC network, and diagnostic
changes that occurred due to detection of additional defects during a one-year follow-up period.
Seven hundred ten liveborn infants with cleft lip only (CLO), cleft lip with cleft palate (CLP), or
cleft palate (CP) were ascertained between 2003 and 2005. Prevalence estimates of isolated and
associated clefts, diagnoses in infants with associated clefts, and the percentage of isolated clefts
that were reclassified as associated were established. Birth prevalence estimates (per 1,000) were
as follows: Total: 1.7; CLP: 0.94 (ASO=23.5%); CP: 0.46 (ASO=42.3%); CLO: 0.28
(ASO=7.6%). Initial diagnoses in infants with associated clefts included 38 infants with
chromosomal abnormalities, 33 with non-chromosomal syndromes, 16 with malformation
sequences, and 98 with multiple anomalies of unknown etiology. Seven percent of newborns
initially classified as isolated were later reclassified as associated. Ten infants without associated
defects or clinically suspected syndromes were diagnosed as syndromic only through laboratory
findings or family history, illustrating the difference between the terms associated vs. isolated,
which refers to presence or absence of associated anomalies, and syndromic vs. non-syndromic,
which refers to etiology.
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Oral clefts as isolated defects, associated with other anomalies or as part of syndromes, are
among the most frequent birth defects [Owens et al., 1985]. The types and rates of
associated defects vary, depending on the age of the infant, the length of follow-up, and
other factors. Such variations across time imply that changes in diagnoses, as well as in
prognosis and recurrence risks, occur as the child gets older and more associated defects are
recognized.
A number of birth defects surveillance systems report birth defect rates in newborn infants
only, while others also include defects detected in older children [ICBDSR, 2009; Bower et
al., 2010], sometimes with variable lengths of follow-up [Milerad et al., 1997; Shaw et al.,
2004], but few of these have focused on the prevalence of additional anomalies recognized
at different ages or on the ages at which those additional anomalies were diagnosed [Tan et
al., 2009; Bower et al., 2010].
ECLAMC (Latin American Collaborative Study of Congenital Malformations) [Castilla and
Orioli, 2004] is a clinical epidemiological program, operating in South America since 1967
that carries out research on birth defects. Between 2003 and 2005, 48 selected maternity
hospitals in the ECLAMC network participated in a special intervention trial that included
regular pediatric visits until one year of age, aimed at evaluating the long-term outcome of
children with oral clefts [Wehby et al., 2006].
The aims of this work were to describe the initial diagnoses of oral clefts (isolated or
associated with other defects) in newborn infants ascertained in hospitals of the ECLAMC
network, and the diagnostic changes that occurred due to detection of additional defects
during a one-year follow-up period.
MATERIAL AND METHODS
In the ECLAMC network, newborn infants with birth defects are ascertained by specially
trained pediatricians, following a common methodology, between birth and hospital
discharge. All information concerning these infants and included in the medical records is
regularly reported by pediatricians to the coordinating group for classification and
registration. Although procedures require that these pediatricians review and update the
clinical information after their initial report, this does not routinely occur.
Within the framework of a special intervention study, infants with clefts ascertained at birth
in 48 maternity hospitals from 7 countries of the ECLAMC network (Argentina, Bolivia,
Brazil, Chile, Colombia, Ecuador, and Venezuela) were followed by their pediatricians until
one year of age with regular physical examinations. Further relevant data were added to the
medical history taken at birth and submitted to the coordinating group.
From a total of 10,371 malformed newborns ascertained among 422,240 livebirths between
January 2003 and December 2005, all infants with oral clefts, except those with bifid uvula,
with clefts of the lip that were medial, oblique atypical, or congenitally “healed”, with
submucous cleft palate, or with birth weight < 500 g, were included in the study. The clefts
were classified as cleft lip with cleft palate (CLP), cleft lip only (CLO), or cleft palate (CP).
Diagnoses and classification of the infants with clefts were based on the information
provided by the pediatricians in the submitted medical records, and on its further evaluation
by dysmorphologists and geneticists of the coordinating group, with the aid of available
photographs, and any other relevant information submitted by the attending pediatricians
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during the one-year follow-up. As part of the study, all infants regardless of their clinical
findings had chromosome analyses performed. Fluorescence in situ hybridization (FISH)
testing for 22q11.2 deletion is not regularly performed at the participating hospitals, and was
not required as part of this study.
Other molecular analyses are also not performed at the hospitals nor were they part of this
work. However, blood samples for DNA analysis were taken from all infants with clefts and
their parents and centralized at a number of laboratories participating in the study for future
research. Preliminary results were obtained from a related project focusing on three genetic
conditions known to be associated with clefts (22q11.2 deletion, van der Woude syndrome,
and Kallmann syndrome). Of the total newborns with clefts included in our study, a
subsample of 79 unselected infants with isolated clefts also participated in that project and
had molecular analyses performed for these three conditions.
Based on the initial information provided by the reporting pediatricians, clefts were initially
classified as isolated or associated, depending on the presence of other major unrelated
defects detected and reported between birth and hospital discharge. Major defects were
defined as those requiring medical or surgical intervention, or of substantial cosmetic
importance, as well as clinically recognizable or suspected syndromes. Infants in whom an
oral cleft without other major anomalies was diagnosed were classified as having an isolated
cleft, while those with additional major defects were classified as having an associated cleft.
All defects were coded according to a specific descriptive system previously described for
oral clefts [Castilla and Orioli, 2009], as well as for other anomaly types [Castilla and Orioli,
2004]. Prevalence estimates and proportions of isolated and associated cases were obtained
for each type of cleft. Mortality rates were established for the isolated group by type of cleft.
Infants with associated clefts were assigned to one of 4 diagnostic groups: chromosomal
abnormalities, other clinically recognized or suspected syndromes, malformation complexes/
sequences, and multiple congenital anomalies of unknown cause (MCA) (clefts with other
major unrelated defects without an identified etiology).
Considering the inconsistent definition of Pierre Robin sequence applied in clinical practice
and consequently its possible over- or under-reporting, Pierre Robin was classified as
isolated CP.
During the one year follow-up period, additional birth defects that were detected and any
other relevant information submitted by the attending pediatricians were added to the initial
diagnoses, thus leading to the reassignment of a number of infants with isolated clefts to the
associated group. The reports of all infants were re-evaluated at the end of the one-year
period.
The study was reviewed and approved by the ethics committee of each participating
hospital, and signed parental consent was obtained for the infants with clefts included in the
study.
RESULTS
A total of 710 liveborn infants with oral clefts were included in the study (total birth
prevalence= 1.7/1,000 livebirths) (Table I). CLP was the most frequent type (birth
prevalence= 0.94/1,000; 55.6%), followed by CP (birth prevalence= 0.46/1,000; 27.6%), and
by CLO (birth prevalence= 0.28/1,000; 16.8%). Most (73.9%) infants were initially
classified as having an isolated cleft, with the remainder (26.1%) classified as having an
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associated cleft. Nearly half of the newborns with CP (42.3%), 23.5% of those with CLP,
and 7.6% of those with CLO had associated anomalies.
Mortality
Among 525 newborns with isolated clefts, 14 (2.6%) died. All deaths occurred during the
first month of life, except one that occurred at 5 months, with no further available data. Nine
of the 14 who died were preterm with birth weights between 500 and 1700 g, and the main
cause of death was related to prematurity. Among the remaining infants, three died of
aspiration and pneumonia and one died after developing a chylothorax. No autopsies were
performed. Five of the 14 infants who died had a CLO (4.5% of all infants with isolated
CLO), the remaining 9 who died had a CLP (3% of all infants with isolated CLP), while no
deaths occurred among infants with an isolated CP.
Among 185 newborns with associated clefts, 87 (47%) died, and all deaths except one
occurred during the first month of life. These infants all had severe associated anomalies or
syndromes.
Diagnoses of associated cases
Cytogenetic testing was performed in 281 infants with clefts initially diagnosed as isolated
and in 108 infants with associated clefts (total results= 55%). The reasons for not obtaining
chromosome results in the rest of the sample were mainly early infant death and failed
cultures.
In Table II, the initial diagnoses of 185 infants with associated clefts are shown. CLP was
the most frequent cleft type in infants with chromosomal abnormalities, while CP
predominated in non-chromosomal syndromes, among which conditions with arthogryposis
were most commonly observed.
Four malformation sequences or complexes without other unrelated defects were diagnosed;
the most frequent was the branchial arch malformation complex in 7 infants (4 with CLP
and 3 with CP). Microtia and preauricular tags were the main associated defects.
The group of MCA was the largest, with 98 infants. However, since chromosome results
were not obtained in almost half of the cases, the inclusion of infants with undetected
chromosome anomalies in this group cannot be ruled out.
Congenital heart defects (CHDs) were by far the defects most frequently associated with
clefts in infants in the MCA group (31/98= 31.6%). However, the proportion of CHDs
associated with clefts among the entire sample of 710 infants (7.7%; 95%CI: 5.4-9.9) did not
differ from the proportion of CHDs associated with other non-cleft anomalies (6.2%;
95%CI: 5.7-6.7), ascertained at the same hospitals and during the same period (data not
shown).
Other associated anomalies in infants with MCA were limb deficiencies (7), anal atresia (6),
hydronephrosis (5), and others with less than 3 cases each. The numbers of all of them were
too small to estimate association rates.
Follow-up
During the one-year follow-up, 38 infant initially diagnosed as having an isolated cleft were
reassigned to the associated group (7.2%), raising the proportion of associated clefts from
26.1 to 31.4%.
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Twenty-four of the 38 infants were reassigned because of the detection of a major defect. In
8 of the 38 infants, the reassignment was based on a clinical re-evaluation of minor
anomalies. The remaining 6 had been incorrectly assigned by the coordinating group and
were appropriately reclassified at the end of the one-year period (Table III).
In most of the 24 infants with additionally detected major anomalies, the detection occurred
within the first month of life; the latest were 2 cases of anal stenosis diagnosed at 1 year of
age. CHDs were the most frequent anomalies detected at older ages, followed by urinary
system and brain anomalies.
Syndromes were identified in the 8 infants whose reassignment was based on a clinical re-
evaluation of minor anomalies: 6 had a chromosomal abnormality, one had Rubinstein-
Taybi syndrome, and one had Cornelia de Lange syndrome. All 8 were diagnosed within the
first week of life, although after having been initially assigned to the isolated clefts group
(Table IV).
In ten infants with isolated clefts, a syndrome was diagnosed after consideration of
laboratory findings or family history information. Since these infants had no other major
defects nor clinically recognizable syndromes, they were not part of the 38 infants
reassigned to the associated clefts group, but remained classified as isolated during the entire
study (Table V).
As expected, none of the infants initially classified as having an associated cleft had to be
reclassified as isolated during the follow-up period.
Infants without follow-up
Of the 511 infants with isolated clefts who were discharged alive, 41 (8%) were lost to
follow-up during the first month and 113 during the rest of the first year (22.1%) (total loss
to follow-up: 30.1%).
Of the 98 infants with associated clefts who were discharged alive, 9 were lost to follow-up
during the first month and 39 during the rest of the first year (total loss to follow-up: 49%).
All infants lost to follow-up remained classified according to their latest diagnoses.
DISCUSSION
In the present study we showed that almost 10% of infants with an apparently isolated oral
cleft in fact had other major defects that were detected during a one-year follow-up period.
However, our study had some limitations: autopsies were not performed on a number of
infants who died, many diagnoses lacked specific laboratory analyses, and a number of
infants were lost to follow-up. Nevertheless, while the lack of specific testing and the loss of
almost half the infants with associated clefts might affect the proportions of specific
diagnoses, they do not affect the overall rate of associated clefts. On the other hand, the loss
of one-third of the infants with apparently isolated clefts precludes an accurate estimate of
the actual prevalence of associated clefts. In large urban areas of developing countries,
community medical programs outside the hospital face serious challenges due to such
problems as unstable families, frequent changes of residence, and the absence of official
registries, all of which make patientś follow-up difficult even for short periods of time.
Notwithstanding the loss of a significant number of infants, it was possible to demonstrate
that at least 7% of those initially diagnosed as having an isolated cleft had other significant
defects. This minimum rose to 9% after including the ten newborns with isolated clefts who
had a syndrome detectable only through laboratory findings or family history. Furthermore,
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less than 10% of the infants without a complete one-year follow-up were lost during the first
month of life, a time when the most severe defects are usually diagnosed.
Since ECLAMC is a hospital-based program, it does not serve as a source for population
rates of clefts and associated conditions. Most ECLAMC hospitals are referral centers for
pregnancies with prenatally detected fetal anomalies and, consequently, their rates of
associated defects diagnosed at birth are probably higher than the population rates.
However, there is no reason to assume that the population rates of anomalies potentially
detectable at older ages are different from the minimum value observed here.
One strength of this study was that within the ECLAMC network, birth defects in newborn
infants are ascertained by pediatricians following a common methodology and strictly
defined operating procedures, thus ensuring reliable and homogeneous data. Furthermore, as
this was a prospective study in which the primary aim was to evaluate outcomes at different
ages, it used a strictly defined protocol in addition to the previously described routine
procedures, and was also free of such well-known limitations as incomplete records or recall
biases that are common in retrospectively obtained data.
Birth prevalence estikmates of cleft types
The highest birth prevalence estimate was found for CLP, followed by CP and CLO. Most
authors have found a similar predominance of CLP while their rates of CP vary, a fact which
might be explained by methodological differences, such as referral sources and ages of the
patients [Wyszynski et al., 2006]. Shprintzen et al. [1985], for instance, observed the highest
rates for CP, but many of their patients were older and it was thus possible to detect less
conspicuous types of cleft, such as submucous CP, which in fact represented 43% of their
CP cases.
The lowest rates have been found for CLO by most authors who evaluated CLO and CLP
separately [Owens et al., 1985; Jensen et al., 1988; Harville et al., 2005; Calzolari et al.,
2007; Genisca et al., 2009]. Barbosa et al. [2003] observed slightly lower CP than CLO
rates, but their patients were from multiple referral sources and of different ages. Rajabian
and Sherkat [2000] reported an excess of CLO in a sample of patients who belonged to a
population with high consanguinity rates. Harville et al. [2005] suggested that children of
consanguineous parents are at a greater risk for CLO than for CLP, and their results suggest
a greater genetic component in the etiology of CLO than in that of CLP.
In the present study, the small sample size only allows us to suggest that CLO was more
frequent among those infants who died (36%) than among the total group with isolated clefts
(21%), and that the mortality rate was higher among infants with CLO than among those
with other types of cleft.
Proportions of associated defects
Reported prevalence estimates of associated defects in patients with clefts are even more
variable, ranging from about 8% [Rajabian and Sherkat, 2000] to 75% in a sample of
prenatally diagnosed fetuses [Lopoo et al., 1999], and again, much of this variation could
reflect methodological differences. For example, Shprintzen et al. [1985] reported that up to
63% of their patients had associated clefts, a finding which was probably due to their
definition of associated anomalies. They considered a cleft as associated even if only minor
defects or facial features often observed with clefts, such as ocular hypertelorism or a
hypoplastic nose, were present. Similarly, the high prevalence of associated anomalies
reported by Shaw et al. [2004] (71.1% for CP and 59.8% for CL with or without CP), could
be due, at least partially, to the inclusion of minor defects. In the present study, a cleft was
defined as associated only when major structural defects or syndromes, identified or strongly
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suspected, were present. The observed 31% of associated defects is similar to the 29%
reported by Shafi et al. [2003] and by Calzolari et al. [2007], and probably higher than the
21% reported by Milerad et al. [1997], but again, all these studies show methodological
differences that hinder a reliable comparison.
CP had the highest prevalence of associated defects, and CLO the lowest. Similar
distributions have been observed by Fraser and Calnan [1961], Stoll et al. [2000], and
Rawashdeh and Jawdat [2008], among others, while Milerad et al. [1997] reported the
highest prevalence for CLP, followed by CP and CLO. The lowest prevalence of associated
defects has been found for CLO by all authors analyzing CLP and CLO separately [Milerad
et al., 1997; Tolarova and Cervenka, 1998; Stoll et al., 2000; Harville et al., 2005; Genisca et
al., 2009].
Diagnoses in associated cases
Chromosomal abnormality syndromes were slightly more frequent than syndromes without
chromosomal abnormalities. Conditions with arthrogryposis predominated among the latter,
with CP as the most frequent type of cleft. This finding was also reported by Rittler et al.
[2008] in a sample partially overlapping that of the present study. CP is often found in
conditions with fetal akinesia, possibly as a consequence of joint immobility during fetal
development [Bannigan and Cottell, 1991].
The most frequent malformation complex or sequence found in our sample of infants with
clefts was the branchial arch complex. Although oral clefts are usually not considered as
diagnostic criteria for the branchial arch “syndrome” (which includes oculoauriculovertebral
syndrome and hemifacial microsomia), they are present in a remarkably high number of
cases in most reviews on branchial arch anomaly conditions [Rollnick et al, 1987; Gorlin et
al., 1990]. The coexistence of ear defects and oral clefts has been described in over 100
syndromes, such as Treacher Collins-Franceschetti, CHARGE, branchiootorenal, Nager, and
Marden-Walker, among others [Baraitser and Winter, 2001]. Rittler et al. [2008] found a
significant association between CLO and severe ear anomalies, while in the study of
Rollnick et al. [1987], CP was the type of cleft most frequently associated with ear defects,
but different sample sources might explain these discordant findings.
Facial morphogenesis is the consequence of complex interacting processes. Different
mechanisms predominate in the development of the external ear and in that of the upper lip
and palate. Mesenchymal underdevelopment of first and second branchial arches, due to a
reduced neural crest migration, can account for external ear malformations while an
impaired or delayed fusion of maxillary and nasal processes, or palatal shelves, leads to a
cleft lip or palate [Farlie et al., 2004; Greene and Pisano, 2010]. However, the preferential
association between ear anomalies and oral clefts suggests that in a certain number of cases,
a specific factor acting through a different pathway, or more extensive damage to the first
and second branchial arches, might be involved. The fact that regions of high altitude
constitute a significant risk factor for both oral clefts and microtia [Castilla and Orioli, 1986;
Castilla et al., 1999] provides further evidence supporting this hypothesis.
Three other complexes/sequences were observed: anencephaly, amniotic bands sequence,
and holoprosencephaly. In anencephalic infants, a cleft palate can be expected, due to the
grossly disorganized skull base, and similarly, Shaw et al. [2004] reported a prevalence of
CP fifty times higher in anencephalic infants than in the overall population.
For the recognized association between clefts and amniotic bands, a number of theories
[Streeter, 1930; Torpin, 1965; Van Allen et al., 1987a) have been proposed although none
has been universally accepted.
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In most patients with holoprosencephaly, the coexisting cleft is midline and this type was
not included in the study. Furthermore, holoprosencephaly is often part of a syndrome or
shows other associated defects [Baraitser and Winter, 2001]. As expected, only one
holoprosencephalic infant with a non-midline cleft lip and without other associated
anomalies was identified.
The largest group of associated clefts was that of MCAs, and CHDs were the most
frequently associated defects, in agreement with Shafi et al. [2003], Rawashdeh and Jawdat
[2008], and Genisca et al., [2009], among others. Milerad et al. [1997] reported that limb
and vertebral column anomalies were the defects that most often coexisted with clefts but
only in infants with more than two anomalies, while CHDs predominated when present as
the only associated defect.
In our study, however, the proportion of infants with clefts and CHDs did not differ from the
proportion of infants with CHDs and other non-cleft anomalies ascertained in the same
hospitals. Furthermore, Rittler et al. [2008] found a significantly negative association
between CHDs and clefts when compared with the association between CHDs and non-cleft
anomalies, and Shaw et al. [2004] observed low relative risks for CHDs in infants with clefts
when compared to the risks for CHDs in infants with other non-cleft anomalies. All these
results could indicate that the association between CHDs and any other defect including
clefts is frequent yet nonspecific.
The present results, which are similar to those of Rawashdeh and Jawdat [2008], show that
CP was the type of cleft most often associated with CHDs. For Liang et al. [1999] the most
frequent type was CLP, and Barbosa et al. [2003] found no correlation between CHDs and
cleft type, but this finding might have been the consequence of their already mentioned
lower CP rates.
Isolated/associated versus non-syndromic/syndromic
In ten infants with isolated clefts in whom other major defects were neither detected nor
suspected during the one-year follow-up period, a syndrome could only be diagnosed
through laboratory findings or family history. This illustrates the difference between the
terms isolated/associated and non-syndromic/syndromic. While the first two refer to the
number of defects, regardless of the cause or the mechanisms involved, the terms
syndromic/non-syndromic refer not to the number of defects but rather to the underlying
common cause that leads to the observed single or multiple anomalies [Benirschke et al.,
1979; Spranger et al., 1982]. However, both terms are often used interchangeably [Tan et al.,
2009], mostly in the recent molecular genetics literature [Mitchell et al., 2003; Carinci et al.,
2007; Song et al., 2008]. For a better understanding and interpretation of descriptions and
results, it seems advisable to use the terms associated/isolated when referring to the presence
or absence of associated defects, and to use the terms syndromic/non-syndromic when
referring to etiology.
Follow-up
The finding that at least 7% of infants initially diagnosed as having isolated clefts actually
had other associated anomalies reflects the facts that certain birth defects are not
recognizable at birth and that the prevalence of diagnosed syndromes and other associated
anomalies increases with age.
Shprintzen et al. [1985] concluded that the higher prevalence of associated anomalies in
older patients when compared to younger patients with clefts was due to the fact that a
submucous cleft palate (which is obviously diagnosed at older ages) associates more
frequently with other defects than an overt cleft palate. It seems more likely, however, that
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both the submucous cleft and the associated anomalies (which were not clearly specified)
reveal themselves independently of each other at older ages.
In the present study, most of the syndromes that were not initially diagnosed were identified
between 7 and 28 days of life and the slight variations depended on the syndrome itself as
well as on the pediatriciańs ability to recognize it. Most of the other major anomalies were
also diagnosed during the first month of life. CHDs were diagnosed at different ages up to a
maximum of nine months (a patent ductus arteriosus that failed to close). This finding
enhances on the one hand the role of follow-up in the more accurate identification of certain
birth defects and syndromes. On the other hand, it allows for adjustments in the rates of birth
defects in newborns without follow-up. Even short periods of time, such as one week, can be
long enough to lead to an underestimation of associated anomalies. Nevertheless, and in
view of the decreasing detection of additional anomalies after the first month of life, the
number of associated defects that still remain undiagnosed after the first year, as well as
their severity, is probably low.
Our finding that at least 7% of infants with apparently isolated clefts in fact have associated
clefts, and that this minimum reaches 9% when infants with isolated clefts and unsuspected
underlying syndromes are included, should be taken into account when newborns without
follow-up are enrolled in studies on the etiology of non-syndromic oral clefts.
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Table III
Reasons for Reassignment of 38 Infants with Isolated Clefts to the Associated Clefts Group, and Final
Diagnoses.
Reason for reassignment and final diagnoses N
1. Detection of major defects (N=24)
  Syndromes 5
  MCA 19
2. Re-evaluation of minor anomalies (N=8)
  Chromosomal abnormality 6
  Rubinstein-Taybi syndrome 1
  Cornelia de Lange syndrome 1
3. Wrong assignment at birth (N=6)
  Chromosomal abnormality 3
  Hydrops fetalis 1
  Lethal skeletal dysplasia 1
  MCA 1
Total 38
MCA: multiple congenital anomalies of unknown cause
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Table V























Sib with Stickler syndrome (
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